The Feb 10 earnings lineup features a heavyweight mix of healthcare, consumer, energy, and industrial leaders.
AstraZeneca ($AZN) opens the pre‑market slate with a $595 billion market cap and $2.18 EPS estimate, setting the tone for global pharma. Coca‑Cola ($KO) follows at $339 billion and $0.56 EPS, providing a read on global consumer demand.
S&P Global ($SPGI) adds a key financial data component with a $133 billion valuation and $4.32 EPS forecast, while BP ($BP) brings energy exposure at $101 billion and $0.57 EPS. CVS Health ($CVS) contributes healthcare‑retail visibility with $0.99 EPS on a $99 billion market cap, and Duke Energy ($DUK) rounds out the utility side with $1.51 EPS expected.
After hours, Gilead ($GILD) reports with $1.83 EPS on $189 billion, and Welltower ($WELL) at $1.44 EPS on $134 billion, both providing clarity on biotech and healthcare real‑estate trends.
Marriott ($MAR) at $89 billion and Spotify ($SPOT) at $86 billion finish the pre‑market roster, offering insights into travel recovery and digital streaming margins.
Here's something no journal will tell you.
Many of these metrics can be misleading without proper context and depth.
Other journals/gurus: "Red pnl from 10:30-11:30? stop trading that hr" 🤡
Reality: Actually, 95% of losses came from 2 trades out of 20... 🤓
TradesViz helps you get exactly the insight you need and makes you understand it :)
The journal that grows with you. 🚀
You might switch brokers, but you shouldn't have to switch journals.
TradesViz is built to handle the entire industry ecosystem. We already support the vast majority of major platforms, but we don't stop there.
If you don't see your specific platform listed, simply contact us and we will add it for you.
We are committed to ensuring your trading history remains intact, regardless of who facilitates your orders.
Your data. Your terms.
Are you capturing the move, or just a fraction of it? 🤏
The gap between your "Actual PnL" and the "Best Possible PnL" is your room for growth.
The Best Exit Dashboard calculates the theoretical maximum profit for every trade you took, allowing you to compare your performance against perfection.
The "Best Exit PnL vs Time of Day" chart (top left) helps you spot patterns: Are you consistently selling too early in the morning session while the trend continues to rip?
Don't just be profitable. Be efficient.
Stop switching tabs to do your homework. 📚
A complete trading plan requires more than just a chart. You need to know the engine under the hood.
The Fundamental Data dashboard integrates institutional-grade research directly into your workflow.
From Valuation & TTM metrics like PE Ratios and EBITDA to critical Share Structure details like Float and Short Interest, everything is accessible on a single screen.
You even get direct links to SEC 10K and 10Q Filings so you can verify the source without leaving the platform.
Streamline your research. execute with confidence.
The Feb 9 technical screen reflected sustained momentum and expanding participation across both small‑cap and mid‑cap names.
In the five‑day gainers group, $PBM led with a 388% increase and nearly 100 K shares traded, underscoring speculative strength despite lower volume change. $LIMN and $VRSSF followed with 234% and 144% gains as turnover spiked 63,000% and 11,000%, pointing to aggressive inflows. $AZN and $LITX each advanced more than 80%, the latter supported by 718 K shares, highlighting steady institutional interest. $LBTYB and $KELYB added 63% and 59% respectively, both backed by multi‑million‑percent volume explosions — clear signs of sudden liquidity expansion.
In the “continuous higher highs + green for three days" group, $FATBB drove leadership with a 96% gain, followed by $ASPS up 35%, and $FLXS at 33%. $POWL and $NVST printed 29% and 28%, maintaining consistent multi‑session uptrends. $RRX, $CING, and $LVWR added steady follow‑through with healthy volume growth.
The broad mix of names from speculative to industrials shows expanding market breadth. When such diverse price and volume acceleration persist for several sessions, it typically signals sustained momentum supported by active accumulation rather than short‑term volatility.
The Feb 9 flow screen highlighted a strong defensive rotation, with sharp increases in put‑side premiums across multiple sectors.
$RIO posted the largest move, up 27,155%, indicating heavy downside hedging in materials. $DVA and $NVS followed closely at 4,750% and 4,756%, both showing consistent three‑day build‑ups in protective flow within healthcare. $MCHP and $UUUU printed 4,771% and 2,048%, confirming similar caution in semiconductors and uranium‑linked names.
Consumer discretionary exposure also tightened, with $XLY up 504% as investors layered protection into sector ETFs. $AGQ, $PAAS, and $AVAV each showed four‑digit increases, rounding out broad defensive behavior in metals and industrials.
The $DVA trend chart showed spot strength through the session even as put intensity climbed, a textbook sign of institutional hedging rather than directional selling.
When protective premiums rise steadily over several days across unrelated sectors, it underscores portfolio‑level risk adjustments ahead of potential volatility rather than a single‑sector unwind.
The Feb 9 options flow screen showed concentrated institutional activity across commodities, energy, and semiconductors.
$GLD dominated early flow with two matched sweeps on Feb 20 $450C and $460C lines, totaling roughly $100 million in combined premium. The pairing of large buy and sell orders within seconds indicates rotational hedging around gold exposure rather than directional positioning.
$ET followed as the session’s most active single‑name, with a sequence of call sweeps on Jan 15 2027 $13C trades ranging from $11 million to $21 million each and an aggregate premium over $180 million. The repetition and uniform sizing suggest systematic accumulation by long‑dated buyers.
In semiconductors, $MU printed a $16 million Mar 20 2026 $350P sweep, while $ALB logged two $11 million put sales on Sep 18 2026 $185P, signaling adjustments in materials and tech hedges.
$TSLA’s $22 million split on Mar 6 2026 $430P showed balanced risk management after recent volatility, while $SLV and $NOW added $9–12 million in mid‑range flows, rounding out cross‑sector exposure in silver and software.
Earnings for Feb 9 2026 bring a mixed cross‑sector lineup spanning finance, healthcare, and semiconductors. $APO leads the pre‑market session at a $73 billion market cap with a $1.91 EPS estimate, anchoring asset‑management sentiment. $BDX follows at $58 billion with $2.82 EPS expected, providing a key read on medical device demand, while $IX contributes a $36 billion footprint and diversified exposure through financial services.
After hours, the focus shifts to insurance and cyclicals. $ACGL prints at $36 billion with $2.49 EPS, and $CINF at $26 billion with $2.86 EPS, both offering visibility into underwriting conditions and rate trends. $PFG adds further financial balance at $20 billion and a $2.23 EPS forecast.
Within industrials and semiconductors, $ON reports with a $25 billion cap and a $0.62 EPS estimate, a key signal for electronics and supply‑chain momentum. $L and $CRBG follow at $22 billion and $15 billion respectively, rounding out diversified financial exposure. $MEDP closes the day after hours at $15 billion with a robust $4.18 EPS consensus, spotlighting healthcare research strength.
"Can I visualize ... ?"
Yes.
With TradesViz's AI Q&A and Custom AI widgets, you can visualize almost everything.
Here's an example of showing multiple pnl curves from different accounts.
You can add this to your custom dashboard for custom comparison :)
